ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Anticancer drugs associated with Stevens-Johnson syndrome/toxic epidermal necrolysis

Anticancer drugs associated with Stevens-Johnson syndrome/toxic epidermal necrolysis
SJS TEN
  Number of reported cases   Number of reported cases
Conventional chemotherapy agents
Lenalidomide 13 Thalidomide 4
Docetaxel 4 Procarbazine 3
Thalidomide 3 Methotrexate 3
Methotrexate 3 Gemcitabine 2
Bleomycin 2 Cytarabine 2
Mechlorethamine 1 Pemetrexed 2
Paclitaxel 1 Chlorambucil 2
Fludarabine 1 Docetaxel 1
Temozolomide 1 Doxorubicin 1
Gemcitabine 1 Asparaginase 1
Capecitabine 1 6-mercaptopurine 1
Cladribine 1 Cladribine 1
Etoposide 1 S-1 (tegafur-gimeracil-oteracil potassium) 1
S-1 (tegafur-gimeracil-oteracil potassium) 1 Lenalidomide 1
Peplomycin 1 Treosulfan 1
Total 35 Total 26
Targeted chemotherapy agents and biologics used for cancer therapy
Imatinib 8 Aldesleukin (IL-2) 2
Rituximab 1 Cetuximab 2
Vemurafenib 1 Imatinib 1
Cetuximab 1 Denileukin 1
    Bivatuzumab mertansine 1
    Bortezomib 1
Total 11 Total 8
SJS: Stevens-Johnson syndrome; TEN: toxic epidermal necrolysis; IL-2: interleukin-2.
Adapted from: Rosen AC, Balagula Y, Raisch DW, et al. Life-threatening dermatologic adverse events in oncology. Anticancer Drugs 2014; 25:225. DOI: 10.1097/CAD.0000000000000032. Copyright © 2014. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.
Graphic 115844 Version 4.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟